Vectorite Biomedical

Vectorite Biomedical Financial Debt Ratio

The Financial Debt Ratio of Vectorite Biomedical (4170.TWO) as of Nov 5, 2026 is 5.21 %.

Financial Debt Ratio

5.21 %

Last updated:

Financial Debt Ratio of Vectorite Biomedical is 2019 5.21 % . Financial Debt Ratio of Vectorite Biomedical was 2018 0.00 . It decreases by % higher compared to the previous year.

The Vectorite Biomedical Financial Debt Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Debt Ratio
Date
Financial Debt Ratio
Jan 1, 2014
2.98 TWD
Jan 1, 2015
5.45 TWD
Jan 1, 2016
10.43 TWD
Jan 1, 2017
0.00 TWD
Jan 1, 2018
0.00 TWD
Jan 1, 2019
5.21 TWD
The Vectorite Biomedical Financial Debt Ratio history
YEARFinancial Debt RatioYoY
5.21 %—
0.00—
0.00-100.00%
10.43 %+91.32%
5.45 %+82.94%
2.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Xinpin Biomedical Co., Ltd. established Xinpin Biomedical Group with the concept of “preventing problems before it happens” and is headquartered in Taipei, New Taipei. The firm offers a range of services including immune cell collection, processing and storage, cell preparation safety testing, anti-cancer immunity testing, original design manufacturer or contract development and manufacturing organization services, related medical consulting, and laboratory quality management. Its product portfolio features dendritic cell vaccines and natural killer cell preparations designed for cancer treatment. Products are mainly sold domestically. Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Financial Debt Ratio of Vectorite Biomedical is 5.21 % in 2019.

On Eulerpool you can find the complete historical development of Financial Debt Ratio Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

The financial debt ratio measures interest-bearing financial debt as a percentage of total assets. It isolates funded debt from trade and other non-financial obligations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Debt Ratio's Vectorite Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Vectorite Biomedical

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Vectorite Biomedical